Search Results - "Veser, Anika"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Influenza A virus mimetic nanoparticles trigger selective cell uptake by Figueroa, Sara Maslanka, Veser, Anika, Abstiens, Kathrin, Fleischmann, Daniel, Beck, Sebastian, Goepferich, Achim

    “…Poor target cell specificity is currently a major shortcoming of nanoparticles (NPs) used for biomedical applications. It causes significant material loss to…”
    Get full text
    Journal Article
  2. 2

    Nanoparticle multivalency counterbalances the ligand affinity loss upon PEGylation by Hennig, Robert, Pollinger, Klaus, Veser, Anika, Breunig, Miriam, Goepferich, Achim

    Published in Journal of controlled release (28-11-2014)
    “…The conjugation of receptor ligands to shielded nanoparticles is a widely used strategy to precisely control nanoparticle–cell interactions. However, it is…”
    Get full text
    Journal Article
  3. 3

    Branched Polymer–Drug Conjugates for Multivalent Blockade of Angiotensin II Receptors by Hennig, Robert, Veser, Anika, Kirchhof, Susanne, Goepferich, Achim

    Published in Molecular pharmaceutics (08-09-2015)
    “…The use of angiotensin receptor blockers (ARBs) for treatment of ocular diseases associated with neovascularizations, such as proliferative diabetic…”
    Get full text
    Journal Article
  4. 4

    Structural Properties of Model Phosphatidylcholine Flippases by Langer, Marcella, Sah, Rashmi, Veser, Anika, Gütlich, Markus, Langosch, Dieter

    Published in Chemistry & biology (24-01-2013)
    “…Lipid translocation from one lipid bilayer leaflet to the other, termed flip-flop, is required for the distribution of newly synthesized phospholipids during…”
    Get full text
    Journal Article